Spinal Anesthesia Using Lidocaine and Sufentanil and (Transient Neurological Symptoms) TNS
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients who are submitted for surgery at a local hospital and where spinal anesthesia is indicated.
adults over the age of seventeen years
patient refuse spinal anesthesia
spinal anesthesia is contraindicated
patient is incapable of giving consent
chronic use of analgesics
spinal anesthesia within five days before the actual surgery
Keywords provided by Britt-Marie Berling, Vestre Viken Ringerike Sykehus:
Additional relevant MeSH terms:
Nervous System Diseases
Signs and Symptoms
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action